
What CytoDyn leaders are saying as their stock tumbles
The company is seeking partnerships while two drug programs are on hold. Click here to view original post
The company is seeking partnerships while two drug programs are on hold. Click here to view original post
Ric Kayne, who is an Athira shareholder and business partner to former CEO Leen Kawas, is vying for a seat on the biotech’s board. Click here to view original post
Dick Clark has been with The Portland Clinic since 2015. Click here to view original post
Those who are allergic to peanut butter: rejoice. Allergy Therapeutics’ virus-like particle peanuts allergy candidate is about to enter Phase I trials, and the company has selected AGC Biologics to take on manufacturing duties. AGC […]
Rise in incidence of health failures, dearth of heart donors, surge in patient awareness about health failure treatment options, and technological advancements have boosted the growth of the global ventricular assist devices market PORTLAND, Ore., […]
Increase in consumption of these drugs to combat pain, rise in the geriatric population that is majorly prone to orthopedic pain, and surge in demand for ideal products for treatment of cough, pain, and diarrhea […]
Rise in number of hospital-acquired infections, geriatric population, expansion of the processed food & beverage and increase in adoption of technologies in medical & cosmetic industries drive the growth of global sterilization technologies market. PORTLAND, […]
The company designs new enzymes and applies the technology to agriculture, chemicals and pharmaceuticals, among other fields. Click here to view original post
Copyright © 2023 Biotech Networks, LLC